Jan Tavernier obtained his Ph.D. degree in 1984 on the cloning of interferon and interleukin genes. After an extended stay at Biogen and later at Roche, he returned in 1996 to Ghent University at the VIB Centre for Medical Biotechnology where he founded the Cytokine Receptor Laboratory. His main areas of expertise are cytokine receptor activation and signal transduction, and the analysis of protein-protein interactions. He is currently developing AcTakines: a novel class of safe, generic and off-the-shelf immunocytokines. Jan Tavernier published over 300 refereed manuscripts and holds over 50 patent applications. He is a member of Royal Belgian Academy of Sciences and The Arts.